Literature DB >> 8200031

Contribution of host radioresistant T cells to the clonal elimination of minor lymphocyte stimulatory-1a reactive T cells in mouse bone marrow chimeras.

N Arase1, H Arase, R A Good, K Onoé.   

Abstract

When bone marrow (BM) cells from I-E+ and minor lymphocyte stimulatory (Mls) antigen (Ag) disparate mice (Mls-1b) were transplanted to lethally irradiated Mls-1a mice, Mls-1a reactive T cells were found to be completely deleted from the developing thymocyte population in these [Mls-1b-->Mls-1a] radiation chimeras. It has been shown that BM-derived class II (Ia) positive cells play an essential role in this clonal deletion. Thus, Mls-1a Ag appeared to have been transferred from recipient cells to the Ia+ cells derived from donor BM. These Mls-1a-Ia complexes appear to be responsible for elimination of the Mls-1a reactive T cells that have also been derived from donor BM. However, definition of the cells of the recipient that generate the Mls-1a Ag and transfer them to the BM-derived Ia+ cells has remained unclear to date. In the analysis described herein, we have investigated the tolerogenicity of Mls-1a Ag derived from host T cells which represent a major population of radioresistant cells in the [Mls-1b-->Mls-1a] chimeras. When recipient T cells that had been collected and purified from spleens of [Mls-1b-->Mls-1a] chimeras were administered i.v. into [Mls-1b] chimeras, Mls-1a reactive V beta 6+, V beta 8.1+, or V beta 9+ T cells were completely eliminated. Thus, residual radioresistant host T cells present in the radiation BM chimeras are the cells which produce the Mls-1a Ag. These Mls-1a Ags ultimately contribute to the clonal elimination of Mls-1a reactive T cells from the developing thymocyte population. The present findings indicate that recipient T cells which can survive lethal irradiation and produce intrinsic superantigens alter eventually the T cell repertoire in the thymus which have been developing from precursors of donor BM.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200031     DOI: 10.1006/cimm.1994.1149

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

1.  Endogenous collagen peptide activation of CD1d-restricted NKT cells ameliorates tissue-specific inflammation in mice.

Authors:  Yawei Liu; Anna Teige; Emma Mondoc; Saleh Ibrahim; Rikard Holmdahl; Shohreh Issazadeh-Navikas
Journal:  J Clin Invest       Date:  2010-12-13       Impact factor: 14.808

2.  Phenotypic and functional modulation of T cells in vivo by extrathymic T cells when T cells with MHC class II disparity were injected into athymic nude mice.

Authors:  K Tomiyama; H Watanabe; S Seki; M Ito; T Abo
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

3.  Essential role for autophagy during invariant NKT cell development.

Authors:  Mariolina Salio; Daniel J Puleston; Till S M Mathan; Dawn Shepherd; Amanda J Stranks; Eleni Adamopoulou; Natacha Veerapen; Gurdyal S Besra; Georg A Hollander; Anna Katharina Simon; Vincenzo Cerundolo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

4.  Transcriptome and Function of Novel Immunosuppressive Autoreactive Invariant Natural Killer T Cells That Are Absent in Progressive Multiple Sclerosis.

Authors:  Belinda Carrión; Yawei Liu; Mahdieh Hadi; Jon Lundstrom; Jeppe Romme Christensen; Cecilie Ammitzbøll; Morten Hanefeld Dziegiel; Per Soelberg Sørensen; Manuel Comabella; Xavier Montalban; Finn Sellebjerg; Shohreh Issazadeh-Navikas
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-08-12

5.  Granulocyte Macrophage-Colony Stimulating Factor Produces a Splenic Subset of Monocyte-Derived Dendritic Cells That Efficiently Polarize T Helper Type 2 Cells in Response to Blood-Borne Antigen.

Authors:  Seul Hye Ryu; Hyun Soo Shin; Hye Hyeon Eum; Ji Soo Park; Wanho Choi; Hye Young Na; Hyunju In; Tae-Gyun Kim; Sejung Park; Soomin Hwang; Moah Sohn; Eun-Do Kim; Kyoung Yul Seo; Hae-Ock Lee; Min-Geol Lee; Min Kyung Chu; Chae Gyu Park
Journal:  Front Immunol       Date:  2022-01-03       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.